沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09996 沛嘉医疗-B

已收盘 07-23 16:08:06

4.300

+0.120

+2.87%

最高4.460	最低4.180	成交量107.60万
今开4.220	昨收4.180	日振幅6.70%
总市值29.03亿	流通市值29.03亿	总股本6.75亿
成交额465.54万	换手率0.16%	流通股本6.75亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09996","market":"HK","secType":"STK","nameCN":"沛嘉医疗-B","latestPrice":4.3,"timestamp":1784794086009,"preClose":4.18,"halted":0,"volume":1076000,"delay":0,"changeRate":0.028708133971291894,"floatShares":675000000,"shares":675000000,"eps":-0.305587,"marketStatus":"已收盘","change":0.12,"latestTime":"07-23 16:08:06","open":4.22,"high":4.46,"low":4.18,"amount":4655410,"amplitude":0.066986,"askPrice":4.3,"askSize":44000,"bidPrice":4.28,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-0.34006,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1784856600000},"marketStatusCode":5,"adr":0,"listingDate":1589472000000,"exchange":"SEHK","adjPreClose":4.18,"openAndCloseTimeList":[[1784770200000,1784779200000],[1784782800000,1784793600000]],"volumeRatio":1.156098,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09996","defaultTab":"news","newsList":[{"id":"2653660957","title":"敷尔佳（301371）披露获得医疗器械注册证公告，7月22日股价下跌0.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653660957","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653660957?lang=zh_cn&edition=full","pubTime":"2026-07-22 22:47","pubTimestamp":1784731633,"startTime":"0","endTime":"0","summary":"截至2026年7月22日收盘，敷尔佳报收于23.35元，较前一交易日下跌0.85%，最新总市值为121.44亿元。该股当日开盘23.46元，最高23.76元，最低23.03元，成交额达5549.6万元，换手率为3.06%。近日，哈尔滨敷尔佳科技股份有限公司披露公告显示，公司于2026年7月20日获得黑龙江省药品监督管理局颁发的医疗器械注册证（Ⅱ类），产品名称为“医用透明质酸钠依克多因修复贴”，注册证编号为黑械注准20262140022，有效期至2031年7月19日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200047793.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09996","BK1574","BK1100","301371","BK0229","BK1583","159883"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653777756","title":"山外山最新公告：全资子公司取得一次性使用血液透析管路医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2653777756","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653777756?lang=zh_cn&edition=full","pubTime":"2026-07-22 17:55","pubTimestamp":1784714121,"startTime":"0","endTime":"0","summary":"山外山(688410.SH)公告称，公司全资子公司重庆天外天生物技术有限公司近日收到国家药监局颁发的《医疗器械注册证》，产品为“一次性使用血液透析管路”，适用于血液透析、血液滤过、血液透析滤过、血液透析联合灌流治疗时建立体外循环通道。该注册证为首次注册，有效期至2031年7月19日。公司表示，该产品将拓展血液净化耗材产品线，完善产品矩阵，提升市场竞争力。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200037106.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1100","09996","159883","BK1583","688410","BK1574","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653756936","title":"乐心医疗（300562）披露控股子公司完成医疗器械注册证变更公告，7月22日股价下跌0.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653756936","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653756936?lang=zh_cn&edition=full","pubTime":"2026-07-22 17:42","pubTimestamp":1784713357,"startTime":"0","endTime":"0","summary":"截至2026年7月22日收盘，乐心医疗报收于12.41元，较前一交易日下跌0.56%，最新总市值为27.12亿元。该股当日开盘12.34元，最高12.9元，最低12.21元，成交额达1.21亿元，换手率为5.81%。公司近日披露《关于控股子公司完成医疗器械注册证变更的公告》。公告显示，广东乐心医疗电子股份有限公司控股子公司深圳市瑞康宏业科技开发有限公司完成心电工作站第二类医疗器械注册证变更，注册证编号为粤械注准20172071166，产品规格型号包括ePCECG-12、ePCECG-12a、ePCECG-12b、ePCECG-18。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200036341.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK1100","300562","BK0109","BK1583","159883","BK0114","09996","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653530047","title":"敷尔佳最新公告：获得医用透明质酸钠依克多因修复贴医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2653530047","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653530047?lang=zh_cn&edition=full","pubTime":"2026-07-22 16:56","pubTimestamp":1784710600,"startTime":"0","endTime":"0","summary":"敷尔佳(301371.SZ)公告称，公司于2026年7月20日获得黑龙江省药品监督管理局颁发的Ⅱ类医疗器械注册证，产品名称为“医用透明质酸钠依克多因修复贴”，有效期至2031年7月19日。该产品用于非慢性创面及周围皮肤护理，有助于丰富公司医疗器械产品线，提升在专业皮肤护理市场的拓展能力。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200034815.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","BK1574","09996","301371","BK1583","159883","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653020655","title":"凯普生物（300639）披露全资子公司变更医疗器械生产许可证公告，7月21日股价下跌1.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653020655","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653020655?lang=zh_cn&edition=full","pubTime":"2026-07-21 22:41","pubTimestamp":1784644908,"startTime":"0","endTime":"0","summary":"截至2026年7月21日收盘，凯普生物报收于5.07元，较前一交易日下跌1.93%，最新总市值为32.78亿元。该股当日开盘5.12元，最高5.13元，最低4.85元，成交额达9229.72万元，换手率为2.92%。近日，广东凯普生物科技股份有限公司全资子公司广州凯普医药科技有限公司取得广东省药品监督管理局颁发的《医疗器械生产许可证》，生产范围变更为III类6840体外诊断试剂，许可证有效期至2027年11月16日。企业名称、住所、法定代表人、企业负责人及生产地址等信息已明确列示。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100045358.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK0239","BK0132","09996","BK1583","159883","300639","BK1100","BK0042","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653051602","title":"达安基因（002030）披露取得乙型肝炎病毒核酸测定试剂盒医疗器械注册证，7月21日股价下跌1.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653051602","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653051602?lang=zh_cn&edition=full","pubTime":"2026-07-21 22:28","pubTimestamp":1784644114,"startTime":"0","endTime":"0","summary":"截至2026年7月21日收盘，达安基因报收于5.13元，较前一交易日下跌1.91%，最新总市值为72亿元。该股当日开盘5.2元，最高5.23元，最低5.03元，成交额达1.1亿元，换手率为1.54%。近日，广州达安基因股份有限公司取得国家药品监督管理局颁发的医疗器械注册证，产品名为乙型肝炎病毒核酸测定试剂盒，注册证编号国械注准20263401474，有效期至2031年7月15日。该产品用于体外定量检测人血清或血浆样本中乙型肝炎病毒脱氧核糖核酸的含量。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100044914.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","159883","BK0046","BK0122","BK0168","BK0159","BK0188","BK1574","002030","BK1583","BK1100","BK0042","09996","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652230620","title":"每周股票复盘：浩欧博（688656）子公司获7项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2652230620","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652230620?lang=zh_cn&edition=full","pubTime":"2026-07-19 02:38","pubTimestamp":1784399890,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，浩欧博报收于81.51元，较上周的96.72元下跌15.73%。本周，浩欧博7月16日盘中最高价报99.85元。浩欧博当前最新总市值51.77亿元，在医疗器械板块市值排名62/129，在两市A股市值排名2884/5199。本周关注点公司公告汇总：全资子公司湖南浩欧博获7项医疗器械注册证，涉及多种过敏原检测试剂盒。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071900000810.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1100","BK1574","BK0239","688656","BK1583","159883","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652308062","title":"每周股票复盘：步长制药（603858）控股子公司医疗器械经营许可变更","url":"https://stock-news.laohu8.com/highlight/detail?id=2652308062","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652308062?lang=zh_cn&edition=full","pubTime":"2026-07-19 02:17","pubTimestamp":1784398628,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，步长制药报收于15.56元，较上周的15.49元上涨0.45%。本周关注点来自公司公告汇总：控股子公司上海合璞医疗完成医疗器械经营许可证变更，经营范围扩大至多类三类器械及体外诊断试剂。公司公告汇总山东步长制药股份有限公司控股子公司上海合璞医疗科技有限公司近日完成《医疗器械经营许可证》的变更登记，变更内容包括经营范围和库房地址。步长（香港）累计质押股份101,530,000股，占其所持股份的20.68%，占公司总股本的9.63%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071900000631.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK0239","159883","BK1583","BK1100","09996","BK0196","603858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652281853","title":"透景生命（300642）披露子公司注销医疗器械注册证公告，7月17日股价下跌7.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652281853","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652281853?lang=zh_cn&edition=full","pubTime":"2026-07-17 22:45","pubTimestamp":1784299516,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，透景生命报收于12.58元，较前一交易日下跌7.5%，最新总市值为20.41亿元。公司于近日披露《关于子公司注销医疗器械注册证的公告》。公告显示，上海透景生命科技股份有限公司全资子公司湖南透景生命科技有限公司因公司整体业务布局优化与内部资源整合，于2026年7月10日完成26项医疗器械注册证的注销手续。上述产品前期已由公司全资子公司江西透景生命科技有限公司报批并取得相关注册证，江西透景已具备相应的生产条件。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700045212.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1100","BK0042","09996","BK1583","BK0046","BK1574","300642","159883","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652289567","title":"新华医疗（600587）披露公司产品获得三类和二类医疗器械注册证公告，7月17日股价下跌0.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652289567","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652289567?lang=zh_cn&edition=full","pubTime":"2026-07-17 22:22","pubTimestamp":1784298138,"startTime":"0","endTime":"0","summary":"近日，新华医疗披露《关于公司产品获得三类和二类医疗器械注册证的公告》。公告显示，公司子公司新华手术器械有限公司获得三类医疗器械注册证，产品为超声软组织手术设备，适用于医疗机构中软组织的切割止血，可闭合直径不超过5mm的血管；另一子公司山东新华医用环保设备有限公司获得二类医疗器械注册证，产品为医用空气压缩机组，用于制取医用压缩空气，为医疗机构集中供气系统提供气源。两项产品注册证有效期均为5年。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700044856.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1100","600587","BK0028","BK1574","BK0188","BK0251","09996","BK1583","159883"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652940991","title":"新华医疗最新公告：子公司获超声软组织手术设备及医用空气压缩机组医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2652940991","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652940991?lang=zh_cn&edition=full","pubTime":"2026-07-17 17:05","pubTimestamp":1784279146,"startTime":"0","endTime":"0","summary":"新华医疗(600587.SH)公告称，公司子公司新华手术器械有限公司近日获得国家药监局颁发的三类医疗器械注册证(超声软组织手术设备)，子公司山东新华医用环保设备有限公司获得山东省药监局颁发的二类医疗器械注册证(医用空气压缩机组)。上述产品将增强公司在微创外科及医疗气体领域的竞争力，但实际销售情况受市场推广影响，存在不确定性。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700030965.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600587","BK1583","BK0028","09996","BK1574","159883","BK0188","BK0251","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652785473","title":"【券商聚焦】中信建投：建议关注Q2医疗设备高增长公司配置机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2652785473","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652785473?lang=zh_cn&edition=full","pubTime":"2026-07-17 08:56","pubTimestamp":1784249774,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券研究指，板块26Q1业绩整体承压。医疗设备预计Q2招标偏弱，部分企业新品及海外驱动增长；医疗器械上游部分公司收入有望高增长；高值耗材受医疗合规要求提升影响，部分企业预计增长良好；IVD低基数下增速有望改善；家用器械部分企业有望延续高增长；医疗服务边际有所回暖。建议关注Q2高增长公司的配置机会，建议关注国产替代向中高端延伸，看好出海、新科技（AI、脑机接口）及并购整合等新技术落地。","market":"us","thumbnail":"https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1986094","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1501","BK1587","09996","BK1615","BK1617","BK1591","BK1589","BK1574","BK1584","01066","BK1593","LU0287142896.SGD","BK0276","02235","601066","BK1247","HK0000165453.HKD","06826","BK1142","BK1100","BK1222","BK1571","02190","BK1610","BK1600","BK1585","BK1161","BK1502","00241","159873","01302","02252","BK1515","LU0173614495.USD","KCE","BK1189","BK1583","00853"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651428357","title":"步长制药（603858）披露控股子公司完成医疗器械经营许可证变更登记公告，7月16日股价上涨0.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651428357","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651428357?lang=zh_cn&edition=full","pubTime":"2026-07-16 22:29","pubTimestamp":1784212152,"startTime":"0","endTime":"0","summary":"截至2026年7月16日收盘，步长制药报收于16.17元，较前一交易日上涨0.75%，最新总市值为170.52亿元。该股当日开盘15.91元，最高16.27元，最低15.82元，成交额达1.58亿元，换手率为0.93%。近日，山东步长制药股份有限公司发布《关于控股子公司完成医疗器械经营许可证变更登记的公告》。公告显示，其控股子公司上海合璞医疗科技有限公司完成《医疗器械经营许可证》的变更登记，主要涉及经营范围和库房地址的变更。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600040301.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159883","BK1583","603858","BK0196","BK1574","09996","BK1100","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651450444","title":"三鑫医疗最新公告：控股子公司人工血管产品进入创新医疗器械特别审查程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2651450444","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651450444?lang=zh_cn&edition=full","pubTime":"2026-07-16 18:51","pubTimestamp":1784199072,"startTime":"0","endTime":"0","summary":"三鑫医疗(300453.SZ)公告称，近日，公司控股子公司江西钶维肽生物科技有限公司自主研发的人工血管产品获得国家药监局医疗器械技术审评中心同意，进入创新医疗器械特别审查程序。进入创新医疗器械特别审查程序的创新医疗器械产品，在注册申报时可享受优先办理的权益，药品监督管理部门及相关技术机构将按照早期介入、专人负责、科学审查的原则，在标准不降低、程序不减少的前提下进行审评审批。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600032911.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159883","09996","300453","BK1100","BK1574","BK1583","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651121124","title":"祥生医疗：乳腺人工智能超声机器人获医疗器械检测报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2651121124","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651121124?lang=zh_cn&edition=full","pubTime":"2026-07-16 16:06","pubTimestamp":1784189168,"startTime":"0","endTime":"0","summary":"证券之星消息，祥生医疗07月16日在投资者关系平台上答复投资者关心的问题。公司自主研发的“乳腺人工智能超声机器人”已率先获得医疗器械检测报告。这些技术已深度融入“AI+机器人扫查”解决方案，为恶性肿瘤群体性筛查提供创新路径。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600025706.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159883","BK0251","161631","BK1574","BK1583","09996","BK1100","688358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651411685","title":"重药控股：主要从事医药流通、医药研发（MAH）、医疗器械生产并投资参与医药工业","url":"https://stock-news.laohu8.com/highlight/detail?id=2651411685","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651411685?lang=zh_cn&edition=full","pubTime":"2026-07-16 15:03","pubTimestamp":1784185395,"startTime":"0","endTime":"0","summary":"证券之星消息，重药控股(000950)07月16日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘，实验猴子价格越来越贵，会不会影响公司对创新药的研发？影响公司发展？重药控股回复：公司处于医药流通行业，主要从事医药流通、医药研发（MAH）、医疗器械生产并投资参与医药工业，其中医药流通为核心业务；医药研发主要以药品上市许可持有人的方式开展，目前以高端仿制药和特色现代中药为主。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600019000.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","000950","09939","BK1100","BK1583","BK1515","159938","09996","159883","BK1161","BK0250","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651454578","title":"浩欧博最新公告：全资子公司获7项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2651454578","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651454578?lang=zh_cn&edition=full","pubTime":"2026-07-15 18:11","pubTimestamp":1784110291,"startTime":"0","endTime":"0","summary":"浩欧博(688656.SH)公告称，公司全资子公司湖南浩欧博生物医药有限公司近日获得7项由湖南省药品监督管理局核准签发的医疗器械注册证，包括过敏原特异性IgE抗体检测试剂盒(坚果混合FX28、霉菌混合MX14、树木混合TX1、海鲜混合FX3、水果混合FX30、草混合WX1)及热带无爪螨过敏原特异性IgE抗体测定试剂盒。上述产品均采用磁微粒化学发光法，用于过敏症的辅助诊断。此次获证丰富了公司化学发光平台检测菜单，有助于提升市场竞争力，但实际销售情况取决于未来市场拓展效果。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500037349.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","688656","BK1100","BK1574","09996","159883","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651102503","title":"新华医疗（600587）披露公司产品获得二类医疗器械注册证的公告，7月14日股价上涨1.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651102503","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651102503?lang=zh_cn&edition=full","pubTime":"2026-07-14 22:52","pubTimestamp":1784040733,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘，新华医疗报收于12.27元，较前一交易日上涨1.15%，最新总市值为74.44亿元。该股当日开盘12.08元，最高12.43元，最低12.05元，成交额达1.01亿元，换手率为1.35%。近日，山东新华医疗器械股份有限公司及子公司新华手术器械有限公司获得山东省药品监督管理局颁发的两项二类医疗器械注册证。产品分别为移动式C形臂X射线机和尿道膀胱镜。两款产品注册证有效期均为五年。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400050036.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","09996","BK0251","BK1100","600587","BK0188","BK0028","BK1583","159883"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651372102","title":"中红医疗（300981）披露子公司完成医疗器械变更注册公告，7月14日股价上涨3.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651372102","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651372102?lang=zh_cn&edition=full","pubTime":"2026-07-14 22:47","pubTimestamp":1784040430,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘，中红医疗报收于10.29元，较前一交易日上涨3.0%，最新总市值为44.13亿元。该股当日开盘9.9元，最高10.32元，最低9.89元，成交额达5078.44万元，换手率为1.27%。近日，中红医疗披露关于子公司江西科伦医疗器械制造有限公司完成医疗器械变更注册的公告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400049926.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","09996","BK1583","159883","BK1100","300981","BK0220"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651104781","title":"爱朋医疗（300753）披露拟参与瑞神安医疗器械股权竞标公告，7月14日股价上涨3.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651104781","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651104781?lang=zh_cn&edition=full","pubTime":"2026-07-14 22:34","pubTimestamp":1784039654,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘，爱朋医疗报收于19.2元，较前一交易日上涨3.67%，最新总市值为24.2亿元。近日，爱朋医疗发布《关于授权公司参与对外投资竞标的公告》。公告显示，公司于2026年7月12日召开第四届董事会第五次会议，审议通过《关于授权公司参与对外投资竞标的议案》，同意公司参与常州产权交易所有限公司挂牌的常州瑞神安医疗器械有限公司4.8294%股权转让竞标，挂牌底价为5361万元，最终受让价格以竞拍结果为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400049779.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1100","300753","BK1574","BK0251","09996","BK1583","159883"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.peijiamedical.com","stockEarnings":[{"period":"1week","weight":-0.0279},{"period":"1month","weight":0.0347},{"period":"3month","weight":-0.3889},{"period":"6month","weight":-0.3968},{"period":"1year","weight":-0.4782},{"period":"ytd","weight":-0.3045}],"compareEarnings":[{"period":"1week","weight":0.0086},{"period":"1month","weight":0.0473},{"period":"3month","weight":-0.0395},{"period":"6month","weight":-0.0694},{"period":"1year","weight":-0.0094},{"period":"ytd","weight":-0.0288}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"沛嘉医疗有限公司是一家主要提供介入手术医疗器械产品的投资控股公司。该公司主要运营两个业务分部，经导管瓣膜治疗业务分部和神经介入业务分部。经导管瓣膜治疗业务分部主要从事研发、制造及销售经导管瓣膜治疗医疗器械业务。神经介入业务分部主要从事研发、制造及销售神经介入手术医疗器械业务。该公司的产品包括TaurusOne、TaurusElite等商业化产品。该公司主要在中国境内开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.057115},{"month":2,"riseRate":0.5,"avgChangeRate":0.017515},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.100991},{"month":4,"riseRate":0.8,"avgChangeRate":0.053778},{"month":5,"riseRate":0.6,"avgChangeRate":-0.096849},{"month":6,"riseRate":0.571429,"avgChangeRate":0.041819},{"month":7,"riseRate":0.571429,"avgChangeRate":0.05066},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.086603},{"month":9,"riseRate":0.333333,"avgChangeRate":0.014494},{"month":10,"riseRate":0.5,"avgChangeRate":-0.005393},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.027135},{"month":12,"riseRate":0.666667,"avgChangeRate":0.083675}],"exchange":"SEHK","name":"沛嘉医疗-B","nameEN":"PEIJIA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供沛嘉医疗-B(09996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"沛嘉医疗-B,09996,沛嘉医疗-B股票,沛嘉医疗-B股票老虎,沛嘉医疗-B股票老虎国际,沛嘉医疗-B行情,沛嘉医疗-B股票行情,沛嘉医疗-B股价,沛嘉医疗-B股市,沛嘉医疗-B股票价格,沛嘉医疗-B股票交易,沛嘉医疗-B股票购买,沛嘉医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供沛嘉医疗-B(09996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}